Evoke Pharma Inc (NASDAQ:EVOK)

6.58
Data as of Jul 23
 -0.09 / -1.35%
Today’s Change
6.41
Today|||52-Week Range
14.25
-11.68%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$40.7M

Company Description

Evoke Pharma, Inc. is a pharmaceutical company, which focuses on the development of drugs to treat gastrointestinal, or GI, disorders and diseases. It develops EVK-001a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matt J. D'Onofrio, Cam L. Garner, Scott L. Glenn and David A. Gonyer on January 29, 2007 and is headquartered in San Diego, CA.

Contact Information

Evoke Pharma, Inc.
12555 High Bluff Drive
San Diego California 92130
P:(760) 487-1255
Investor Relations:

Employees

Shareholders

Individual stakeholders56.19%
Other institutional5.73%
Mutual fund holders2.28%

Top Executives

David A. GonyerPresident, Chief Executive Officer & Director
Marilyn R. CarlsonChief Medical Officer
Matthew J. D'OnofrioSecretary, Treasurer, Chief Business Officer & EVP

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.